Vadim Albertovich Makarov

This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 9 EPO patents. Top assignees: Ecole Polytechnique Federale De Lausanne, Collaborations Pharmaceuticals, Inc., Leibniz-Institut Fuer Naturstoff-Forschung Und Infektionsbiologie E.v. Hans-Knoell-Institut. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vadim Albertovich Makarov. Retrieved from https://idiyas.com/inventor/vadim-albertovich-makarov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 8)

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 10(Granted Patents)

Location History:

Moskau, RU (2017)
Moscow, RU (2013 - 2019)

Company Filing History:

3 out of 716

Ecole Polytechnique Federale De Lausanne

patents

1 out of 3

Collaborations Pharmaceuticals, Inc.

patents

1 out of 2

Leibniz-Institut Fuer Naturstoff-Forschung Und Infektionsbiologie E.v. Hans-Knoell-Institut

patents

4. 1 out of 4

Scandion Oncology A/s

patents

5. 1 out of 8

Universitatsklinikum Jena

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12583848 - Isoxazole-3-carboxamide derivatives and their use for treatment of diseases caused by virus infection (2026-03-24),

2. 10358442 - 2-homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides (2019-07-23),

3. 10160754 - 2-homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides (2018-12-25),

4. 9790225 - 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and their use as antiviral active substances (2017-10-17),

5. 8796264 - 2-piperazin-1-yl-4H-1,3-benzothiazin-4-one derivatives and their use for the treatment of mammalian infections (2014-08-05),

6. 8440842 - Antimicrobial compounds, their synthesis and their use for treatment of mammalian infections (2013-05-14),

Title: Vadim Albertovich Makarov: Innovator in Pharmaceutical Chemistry

Introduction

Vadim Albertovich Makarov is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds useful in treating bacterial infections.

Latest Patents

Makarov holds five patents, with his latest innovations focusing on 2-homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives. These compounds are particularly valuable in the treatment of serious bacterial infections, including tuberculosis, buruli ulcer, and leprosy. Additionally, he has developed a process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides, further enhancing the therapeutic potential of these derivatives.

Career Highlights

Throughout his career, Makarov has worked with prestigious institutions, including the École Polytechnique Fédérale de Lausanne and Scandion Oncology A/S. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Makarov has collaborated with notable colleagues such as Cole Stewart and Peter Wutzler. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Vadim Albertovich Makarov is a distinguished inventor whose work in pharmaceutical chemistry has the potential to significantly improve treatments for bacterial infections. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.